-- Data Presented at American Society of Hematology (ASH) Annual Meeting -- With a median follow-up of 12.3 months (range: 7.0 to 32.3 months) at the time of data cutoff, 57 percent of patients ...
– At Almost Four Years of Follow-up in the Pivotal ZUMA-2 Study, Median Overall Survival was 46.4 Months, Supporting Long-Term Response in Adult Patients with Relapsed/Refractory (R/R) Mantle Cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results